Trial Profile
Double-blind comparative study of candesartan cilexetil/hydrochlorothiazide in patients with mild/moderate essential hypertension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 May 2016
Price :
$35
*
At a glance
- Drugs Candesartan cilexetil/hydrochlorothiazide (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Takeda
- 28 May 2016 New trial record